Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 477-480

  Versalovic, James ^a   Shortridge, Dee ^b   Kibler, Kirsten ^a   Griffy, Mamie V ^a   Beyer, Jill ^b   Flamm, Robert K ^b   Tanaka, S Ken ^b   Graham, David Y ^a   Go, Mae F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; ESCHERICHIA COLI; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; PEPTIC ULCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; STOMACH ADENOCARCINOMA;

EID: 0030068225     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.477     Document Type: Article

References (29)

1. Bayerdorffer, E., A. Neubauer, B. Rudolph, C. Thiede, N. Lehn, S. Eidt, M. Stolfe, and MALT Lymphoma Study Group. 1995. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345:1591-1594.
2. Bukanov, N. O., and D. E. Berg. 1994. Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638. Mol Microbiol. 11:509-523.
3. Burette, A., Y. Glupczynski, C. Deprez, E. DeKoster, D. Urbain, J. Vanderauwera, A. Wigerinck, and J. Drnec. 1993. Omeprazole alone or in combination with clarithromycin for eradication of Helicobacter pylori: results of a randomized double blind controlled study. Gastroenterology 104:A49 (Abstract.)
4. Cayla, R., F. Zerbib, P. Talbi, F. Megraud, and H. Lamouliatte. 1995. Preand post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 37(Suppl. 1):A55 (abstr.).
5. Cseplo, A., T. Etzold, J. Schell, and P. H. Schreier. 1988. Point mutations in the 23S rRNA genes of four lincomycin resistant Niconana plumbaginifolia mutants could provide new selectable markers for chloroplast transformation. Mol. Gen. Genet. 214:295-299.
6. Ettayebi, M., S. M. Prasad, and E. A. Morgan. 1985 Chloramphenicolerythromycin resistance in a 23S rRNA gene of Escherichia coli. J. Bacteriol. 162:551-557.
7. Go, M., K. Chan, J. Versalovic, T. Koeuth, D. Y. Graham, and J. R. Lupski. 1995. Cluster analysis of Helicobacter pylori genomic DNA fingerprints suggests gastroduodenal disease-specific associations. Scand. J. Gastroenterol 30:640-646.
8. Goldman, R. C., D. Zakula, R. Flamm, J. Beyer, and J. Capobianco. 1994. Tight binding of clarithromycin, its 14-R-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob. Agents Chemother. 38: 1496-1500.
9. Graham, D. Y., G. M. Lew, P. D. Klein, D. G. Evans, and D. J. Evans, Jr. 1992. Effect of treatment of Helicobacter pylon infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann. Intern. Med. 116:705-708.
10. Hardy, D. J., C. W. Hanson, D. M. Hensey, J. M. Beyer, and P. B. Fernandes. 1988 Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones J. Antimicrob. Chemother. 22:631-636.
11. Harris, E. H., B. D. Burkhart, N. W. Gillham, and J. E. Boynton. 1989 Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardin. correlation of genetic and physical maps of the chloroplast genome. Genetics 123:281-292.
12. Labenz, J., and G. Borsch. 1994. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am. J Gastroenterol. 89:1785-1788.
13. Labenz, J., and C. O'Morain. 1995. Eradication Curr. Opin. Gastroenterol. 11(Suppl. 1):47-51.
14. Logan, R. P. H., P. A. Gummett, H. D. Schaufelberger, R. R. F. H. Greaves, G. M. Mendelson, M. M. Walker, P. H. Thomas, J. H. Baron, and J. J. Misiewicz. 1994. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 35:323-326.
15. Marshall, B. J. 1994. Helicobacter pylori. Am. J. Gastroenterol. 89:S116-S128.
16. Meier, A., P. Kirschner, B. Springer, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Bottger. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
17. Menninger, J. R. 1985. Functional consequences of binding macrolides to ribosomes. J. Mol. Biol. 16:23-34.
18. Moazed, D., and H. F. Noller. 1987. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69:879-884.
19. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. 1994. Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69.
20. Skinner, R., E. Cundliffe, and F. J. Schmidt. 1983. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics J. Biol. Chem. 258:12702-12706.
21. Sor, F., and H. Fukuhara. 1982 Identification of two erythromycin resistance mutations in the mitochondrial gene coding for the large ribosomal RNA in yeast. Nucleic Acids Res. 10:6571-6577.
22. Steigbigel, N. H. 1995. Macrolides and clindamycin, p. 334-346. In G. L. Mandell, J. E Bennett, and R Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York.
23. Stolte, M., and S. Eidt. 1993 Healing gastric MALT lymphomas by eradicating H. pylori? Lancet 342:568.
24. Sung, J. J., S. C. Chung, T. K. Ling, M. Y. Yung, V. K. Leung, E. K. Ng, M. K. Li, A. F. Cheng, and A. K. Li. 1995. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N. Engl. J. Med. 332:139-142.
25. Vaira, D., J. Holton, M. Miglioli, M. Menegatti, P. Mule, and L. Barbara. 1994. Peptic ulcer disease and Helicobacter pylori infection. Curr. Opin. Gastroenterol. 10:98-104.
26. Vester, B., and R. A. Garrett. 1987. A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochimic 69:891-900.
27. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother 39:577-585.
28. Wotherspoon, A. C., C. Doglioni, and T. C. Diss. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-578.
29. Xia, H. X., M. Buckley, D. Hyde, C. T. Keane, and C. A. O'Morain. 1995. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 37(Suppl. 1):A55 (abstr.)